Adeno-associated virus carrier, preparation method thereof and application
A virus vector and virus technology, applied in the field of biomedicine, can solve problems such as difficulty in popularization, complicated AAV vector production and purification technology
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] Example 1 The method for constructing the adeno-associated virus vector of the present invention
[0040] 1. Design and screening of siRNA target sequences capable of interfering with the expression of hepatitis B virus surface antigen-encoding genes: We first determined that the length of the siRNA target sequence was 19-22 bases, and the screening principle was to be able to specifically encode hepatitis B virus The mRNA transcribed by the surface antigen gene is paired and combined, and can selectively degrade it, resulting in down-regulation and inactivation of the expression product of the surface antigen gene of the hepatitis B virus. According to the base sequence of the surface antigen coding gene in hepatitis B virus, we searched for multiple target sequences with lengths of 19, 20, 21, and 22 bases, respectively. The most effective target site UUACUAGUGCCAUUUGUUC and siRNA sequence capable of interfering with the expression of hepatitis B virus surface antigen...
Embodiment 2
[0051] There are differences in the efficiency of different shRNA artificial genes to interfere with the expression of HBsAg.
[0052] We respectively constructed artificial genes that use H1 or U6 as promoters and carry different siRNAs that encode genes targeting HBsAg, that is, shRNA1: SEQ ID NO.2 (GATCCCCCCTACTAGTGCCATTTGTTTCTTCAAGAGAGAACAAATGGCACTAGTAATTTTTGGAAA) or shRNA2: SEQ ID NO. 3 (GATCCGTTACTAGTGCCATTTGTTCTTCAAGAGAGAACAAATGGCACTAGTAAACTTTTTTGGAAA) eukaryotic expression vector, we named pSilencer3.1-H1-HBVSAg-shRNA1, pSilencer3.1-H1-HBVSAg-shRNA2, pSilencer3.1-U6-HBVSAg-shRNA1, pSilencer3.1-U6-HBVSAg -shRNA2. In order to detect the interference efficiency of two artificial genes on the expression of hepatitis B virus surface antigen. We used liposomes to transfer 2 μg of expression plasmids encoding HBsAg (positive control), 2 μg of expression plasmids encoding HBsAg and 2 μg of shRNA encoding HBsAg expression (experimental group) 239 cells cultured in a 6-well pl...
Embodiment 3
[0057] The expression vector is selectively expressed in the liver.
[0058] Using the method of hydrodynamic transfection, 20 μg of the expression plasmid encoding the firefly fluorescent protein (Luc) reporter gene dissolved in 2 ml of normal saline was injected into the tail vein of the small white mouse, and after 24, 48 and 96 hours, respectively, the The small animal imaging system was used to observe the expression level and location of the reporter gene, and it can be seen that the Luc gene can be expressed at a high level in the liver area (see image 3 ).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com